Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of HC-1119 soft capsules in metastatic castration-resistant prostate cancer after failure of abiraterone and docetaxel
CTR20190199Phase 3Completed
- Sponsor
- Hinova Pharmaceuticals Inc.
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deutenzalutamide, sponsored by Hinova Pharmaceuticals Inc.. Started Apr 2019; status: completed.
02
Drugs
deutenzalutamide
Beyond the preview
Go deeper on CTR20190199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190199.